RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Net income margin (%)

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndNet income margin (%) YoY (%)
Dec 31, 2024-9.9+180.83%
Dec 31, 2023-3.5-77.62%
Dec 31, 2022-15.8-648.96%
Dec 31, 20212.9-111.99%
Dec 31, 2020-24+304.87%
Dec 31, 2019-5.9-48.12%
Dec 31, 2018-11.4-84.31%
Dec 31, 2017-72.7-4937.32%
Dec 31, 20161.5-81.52%
Dec 31, 20158.1-46.08%
Dec 31, 201415.1+141.24%
Dec 31, 20136.2-35.34%
Dec 31, 20129.7-36.08%
Dec 31, 201115.1-27.02%
Dec 31, 201020.7

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)